Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies.

× No keyword cloud information.

5 in total

1. The effect of levodopa therapy on dopamine transporter SPECT imaging with( 123)I-FP-CIT in patients with Parkinson's disease.

Authors: Orazio Schillaci; Mariangela Pierantozzi; Luca Filippi; Carlo Manni; Livia Brusa; Roberta Danieli; Giorgio Bernardi; Giovanni Simonetti; Paolo Stanzione
Journal: Eur J Nucl Med Mol Imaging Date: 2005-09-08 Impact factor: 9.236

2. Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.

Authors: Alexander Rossi; Kristin Berger; Honglei Chen; Douglas Leslie; Richard B Mailman; Xuemei Huang
Journal: Mov Disord Date: 2017-06-07 Impact factor: 10.338

Review 3. Neuroimaging and therapeutics in movement disorders.

Authors: Thomas Eckert; David Eidelberg
Journal: NeuroRx Date: 2005-04

4. Changes in network activity with the progression of Parkinson's disease.

Authors: Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal: Brain Date: 2007-04-30 Impact factor: 13.501

5. Impact of subcortical white matter lesions on dopamine transporter SPECT.

Authors: Elisabeth Funke; Andreas Kupsch; Ralph Buchert; Winfried Brenner; Michail Plotkin
Journal: J Neural Transm (Vienna) Date: 2013-01-24 Impact factor: 3.575

5 in total